AWM
CLB icon

Avior Wealth Management’s Core Laboratories CLB Stock Holding History

Avior Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47
Closed -$802 – 2535
2024
Q1 		$802 Buy
+47
New +$739 ﹤0.01% 2449
2020
Q1 		– Sell
-7,615
Closed -$286K – 784
2019
Q4 		$286K Hold
7,615
– – 0.05% 332
2019
Q3 		$355K Hold
7,615
– – 0.06% 261
2019
Q2 		$398K Hold
7,615
– – 0.07% 249
2019
Q1 		$524K Buy
7,615
+2,371
+45% +$159K 0.11% 189
2018
Q4 		$312K Hold
5,244
– – 0.08% 238
2018
Q3 		$607K Hold
5,244
– – 0.13% 152
2018
Q2 		$662K Hold
5,244
– – 0.15% 135
2018
Q1 		$568K Hold
5,244
– – 0.13% 154
2017
Q4 		$574K Buy
+5,244
New +$523K 0.13% 151

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Avior Wealth Management's CLB Position: Q2 2024 in Review

Avior Wealth Management sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 47 shares — an estimated $802 sold.

Avior Wealth Management first reported a position in CLB in Q4 2017 and held it in 10 quarters. The position peaked at $662K in Q2 2018. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Avior Wealth Management reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 47 Core Laboratories shares in Q2 2024, an estimated $802.
  • Avior Wealth Management first reported a position in Core Laboratories in Q4 2017 and held it in 10 quarters.
  • Avior Wealth Management's Core Laboratories position peaked at $662K in Q2 2018.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.